COVID-19 Clinical Trials in Baltimore, Maryland

5 studies are recruiting for covid-19 in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

   This phase 1 randomized, open-label, dose-escalation clinical trial evaluates the safety and immunogenicity of OCU500, a ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine, in healthy adults aged 18-64 who previously completed a primary COVID-19 vaccination series and at least one booster. The study e…

   Stage

   Phase 1

   Ages

   18 to 64

   Site

   University of Maryland, School of Medicine, Center for Vaccine Development and Global Health, Baltimore, Maryland

   Locations

   6 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT07536308 on ClinicalTrials.gov

2. Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

   This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.

   Stage

   Phase 3

   Ages

   Any age

   Site

   The Johns Hopkins Hospital, Baltimore, Maryland

   Locations

   28 in total

   Run by

   Ansun Biopharma, Inc.

   See if you can join NCT03808922 on ClinicalTrials.gov

3. The Impact of COVID-19 on Maternal and Neonatal Outcomes

   The novel coronavirus (SARS-CoV-2) infection (COVID-19) has caused a worldwide pandemic. There is still much that is unknown regarding the virus, especially its effects on pregnancy, the fetus, and the neonate. This study seeks to evaluate adverse pregnancy and neonatal outcomes related to COVID-19…

   Stage

   Not phased

   Ages

   14 to 55

   Site

   Johns Hopkins Hospital, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT05197621 on ClinicalTrials.gov

4. Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities

   The goal of this clinical trial is to find out which approach works better in getting more of the friends and connections of Latino adults get vaccinated against COVID-19. The main questions this study aims to answer are: 1. Can teaching people to use motivational interviewing help more friends and…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Johns Hopkins University, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT06128928 on ClinicalTrials.gov

5. EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

   The purpose of this clinical trial is to learn about the safety, pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it), and efficacy (how well a study treatment works in the study) of the study medicine (called nirmatrelvir/r…

   Stage

   Phase 3

   Ages

   0 to 17

   Site

   Johns Hopkins Hospital, Baltimore, Maryland

   Locations

   73 in total

   Run by

   Pfizer

   See if you can join NCT05261139 on ClinicalTrials.gov